STRS Ohio’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.37M | Sell |
149,152
-14
| -0% | -$975 | 0.04% | 390 |
|
|
2025
Q4 | $9.9M | Sell |
149,166
-74,984
| -33% | -$4.85M | 0.04% | 392 |
|
|
2025
Q3 | $15.1M | Sell |
224,150
-14,796
| -6% | -$1.17M | 0.06% | 330 |
|
|
2025
Q2 | $20.9M | Buy |
238,946
+14,346
| +6% | +$1.12M | 0.08% | 284 |
|
|
2025
Q1 | $15.3M | Buy |
224,600
+35,000
| +18% | +$2.86M | 0.06% | 312 |
|
|
2024
Q4 | $14.7M | Sell |
189,600
-425,000
| -69% | -$31.5M | 0.06% | 310 |
|
|
2024
Q3 | $41.2M | Hold |
614,600
| – | – | 0.16% | 149 |
|
|
2024
Q2 | $69.7M | Buy |
614,600
+160,000
| +35% | +$20.2M | 0.28% | 77 |
|
|
2024
Q1 | $63.1M | Buy |
454,600
+242,000
| +114% | +$30.4M | 0.25% | 98 |
|
|
2023
Q4 | $26.4M | Sell |
212,600
-3,000
| -1% | -$306K | 0.11% | 218 |
|
|
2023
Q3 | $20.1M | Sell |
215,600
-7,593
| -3% | -$856K | 0.09% | 241 |
|
|
2023
Q2 | $28.7M | Buy |
223,193
+23,593
| +12% | +$2.85M | 0.12% | 199 |
|
|
2023
Q1 | $23.2M | Hold |
199,600
| – | – | 0.1% | 251 |
|
|
2022
Q4 | $22.6M | Sell |
199,600
-8,000
| -4% | -$878K | 0.1% | 246 |
|
|
2022
Q3 | $16.7M | Hold |
207,600
| – | – | 0.08% | 279 |
|
|
2022
Q2 | $15.5M | Sell |
207,600
-476,372
| -70% | -$43.5M | 0.07% | 302 |
|
|
2022
Q1 | $87.5M | Buy |
683,972
+46,628
| +7% | +$5.1M | 0.32% | 72 |
|
|
2021
Q4 | $85.6M | Buy |
637,344
+9,372
| +1% | +$1.35M | 0.3% | 76 |
|
|
2021
Q3 | $85.9M | Buy |
627,972
+8,000
| +1% | +$1.01M | 0.32% | 66 |
|
|
2021
Q2 | $66.2M | Buy |
619,972
+90,584
| +17% | +$8.7M | 0.24% | 99 |
|
|
2021
Q1 | $47.6M | Buy |
529,388
+63,456
| +14% | +$5.96M | 0.18% | 146 |
|
|
2020
Q4 | $43.1M | Buy |
465,932
+175,636
| +61% | +$15.7M | 0.17% | 149 |
|
|
2020
Q3 | $29.9M | Sell |
290,296
-36,552
| -11% | -$3.82M | 0.13% | 184 |
|
|
2020
Q2 | $33.1M | Buy |
326,848
+46,520
| +17% | +$4.16M | 0.14% | 168 |
|
|
2020
Q1 | $18.9M | Buy |
280,328
+169,256
| +152% | +$10.5M | 0.1% | 231 |
|
|
2019
Q4 | $6.07M | Buy |
111,072
+101,912
| +1,113% | +$4.83M | 0.03% | 439 |
|
|
2019
Q3 | $341K | Buy |
9,160
+4,788
| +110% | +$186K | ﹤0.01% | 1480 |
|
|
2019
Q2 | $163K | Sell |
4,372
-4,844
| -53% | -$152K | ﹤0.01% | 1741 |
|
|
2019
Q1 | $274K | Buy |
9,216
+3,420
| +59% | +$120K | ﹤0.01% | 1580 |
|
|
2018
Q4 | $173K | Sell |
5,796
-180
| -3% | -$5.71K | ﹤0.01% | 1664 |
|
|
2018
Q3 | $213K | Buy |
+5,976
| New | +$185K | ﹤0.01% | 1705 |
|
|
2017
Q4 | – | Sell |
-4,908
| Closed | -$60K | – | 1893 |
|
|
2017
Q3 | $60K | Buy |
4,908
+760
| +18% | +$13.4K | ﹤0.01% | 1747 |
|
|
2017
Q2 | $75K | Sell |
4,148
-840
| -17% | -$15.5K | ﹤0.01% | 1705 |
|
|
2017
Q1 | $105K | Hold |
4,988
| – | – | ﹤0.01% | 1640 |
|
|
2016
Q4 | $74K | Buy |
+4,988
| New | +$88.4K | ﹤0.01% | 1719 |
|
|
2015
Q2 | – | Sell |
-61,200
| Closed | -$953K | – | 1877 |
|
|
2015
Q1 | $953K | Sell |
61,200
-84,400
| -58% | -$1.28M | ﹤0.01% | 810 |
|
|
2014
Q4 | $2M | Sell |
145,600
-5,600
| -4% | -$68.6K | 0.01% | 615 |
|
|
2014
Q3 | $1.51M | Sell |
151,200
-9,200
| -6% | -$94K | 0.01% | 642 |
|
|
2014
Q2 | $1.59M | Buy |
160,400
+3,200
| +2% | +$28.4K | 0.01% | 628 |
|
|
2014
Q1 | $1.63M | Buy |
157,200
+114,000
| +264% | +$1.18M | 0.01% | 585 |
|
|
2013
Q4 | $382K | Sell |
43,200
-15,200
| -26% | -$120K | ﹤0.01% | 1273 |
|
|
2013
Q3 | $412K | Buy |
58,400
+50,400
| +630% | +$319K | ﹤0.01% | 1268 |
|
|
2013
Q2 | $45K | Buy |
+8,000
| New | +$38.3K | ﹤0.01% | 1744 |
|
Other funds holding DXCM
VCM
VPM
STRS Ohio's DXCM Position: Q1 2026 in Review
STRS Ohio reduced its DexCom (DXCM) stake by 0.01% in Q1 2026, selling an estimated $975 and leaving 149,152 shares worth $9.37M. The position accounts for 0.04% of the portfolio, ranked #390.
STRS Ohio first reported a position in DXCM in Q2 2013 and has held it in 43 quarters since. The position peaked at $87.5M in Q1 2022. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- STRS Ohio held 149,152 shares of DexCom worth $9.37M as of Q1 2026.
- STRS Ohio sold 14 DexCom shares in Q1 2026, an estimated $975.
- DexCom made up 0.04% of STRS Ohio's portfolio in Q1 2026, its #390 holding.
- STRS Ohio first reported a position in DexCom in Q2 2013 and has held it in 43 quarters since.
- STRS Ohio's DexCom position peaked at $87.5M in Q1 2022.
- 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on STRS Ohio's 13F filing for Q1 2026, filed 24 Apr 2026.